Monica M Lahra, Rodney P Enriquez for the for the National Neisseria Network, Australia
The reference laboratories of the Australian Meningococcal Surveillance Programme (AMSP) report data on the number of cases confirmed by laboratory testing using culture and by non-culture based techniques. Culture positive cases, where Neisseria meningitidis is grown from a normally sterile site or skin lesions, and non-culture based diagnoses, derived from results of nucleic acid amplification assays and serological techniques, are defined as invasive meningococcal disease (IMD) according to Public Health Laboratory Network definitions. Data contained in quarterly reports are restricted to a description of the number of cases by jurisdiction and serogroup, where known. Some minor corrections to data in the Table may be made in subsequent reports if additional data are received. A full analysis of laboratory confirmed cases of IMD in each calendar year is contained in the AMSP annual reports published in Communicable Diseases Intelligence.
State or territory | Year | Serogroup | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A | B | C | Y | W | ND/other | All | |||||||||
Q1 | YTD | Q1 | YTD | Q1 | YTD | Q1 | YTD | Q1 | YTD | Q1 | YTD | Q1 | YTD | ||
Australian Capital Territory | 2017 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2016 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
New South Wales | 2017 | 0 | 0 | 9 | 9 | 2 | 2 | 2 | 2 | 3 | 3 | 0 | 0 | 16 | 16 |
2016 | 0 | 0 | 5 | 5 | 1 | 1 | 0 | 0 | 4 | 4 | 3 | 3 | 13 | 13 | |
Northern Territory | 2017 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 2 | 2 |
2016 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Queensland | 2017 | 0 | 0 | 12 | 12 | 0 | 0 | 7 | 7 | 3 | 3 | 0 | 0 | 22 | 22 |
2016 | 0 | 0 | 4 | 4 | 0 | 0 | 4 | 4 | 2 | 2 | 0 | 0 | 10 | 10 | |
South Australia | 2017 | 0 | 0 | 1 | 1 | 0 | 0 | 2 | 2 | 2 | 2 | 0 | 0 | 5 | 5 |
2016 | 0 | 0 | 6 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 6 | |
Tasmania | 2017 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 4 | 4 | 0 | 0 | 5 | 5 |
2016 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 0 | 0 | 2 | 2 | |
Victoria | 2017 | 0 | 0 | 4 | 4 | 0 | 0 | 4 | 4 | 7 | 7 | 1 | 1 | 16 | 16 |
2016 | 0 | 0 | 3 | 3 | 1 | 1 | 0 | 0 | 5 | 5 | 0 | 0 | 9 | 9 | |
Western Australia | 2017 | 0 | 0 | 3 | 3 | 1 | 1 | 0 | 0 | 4 | 4 | 1 | 1 | 9 | 9 |
2016 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 2 | 2 | 0 | 0 | 3 | 3 | |
Total | 2017 | 0 | 0 | 30 | 30 | 3 | 3 | 16 | 16 | 24 | 24 | 2 | 2 | 75 | 75 |
2016 | 0 | 0 | 19 | 19 | 2 | 2 | 4 | 4 | 15 | 15 | 3 | 3 | 43 | 43 |
Author details
Monica M Lahra1,2
Rodney P Enriquez1
- Neisseria Reference Laboratory and World Health Organization Collaborating Centre for STD, Sydney. Department of Microbiology, South Eastern Area Laboratory Services, The Prince of Wales Hospital, Randwick, New South Wales
- School of Medical Sciences, Faculty of Medicine, The University of New South Wales, New South Wales
CDI Search
Communicable Diseases Intelligence subscriptions
Sign-up to email updates: Subscribe Now
Communicable Diseases Surveillance